B7H3​-MMAE (Anwita Bioscience)

N/A

Report date: 2021/12/08 15:58:23

Base Information

Drug NameB7H3​-MMAE (Anwita Bioscience)
Drug Alias NameB7H3​-MMAE
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionCD276 antigen inhibitorsTubulin inhibitors
TargetsCD276 antigenTubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnwita Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnwita Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A